🇺🇸 COVID-19 mRNA vaccine in United States
42 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 42
Most-reported reactions
- Epilepsy — 5 reports (11.9%)
- Off Label Use — 5 reports (11.9%)
- Aphasia — 4 reports (9.52%)
- Aspergillus Infection — 4 reports (9.52%)
- Bronchopulmonary Aspergillosis — 4 reports (9.52%)
- Covid-19 — 4 reports (9.52%)
- Cytokine Release Syndrome — 4 reports (9.52%)
- Drug Ineffective — 4 reports (9.52%)
- Encephalitis — 4 reports (9.52%)
- Headache — 4 reports (9.52%)
COVID-19 mRNA vaccine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is COVID-19 mRNA vaccine approved in United States?
COVID-19 mRNA vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for COVID-19 mRNA vaccine in United States?
Vaccine Company, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.